[{"Assets_0_Q2_USD":615745000.0,"CommonStockSharesOutstanding_0_Q2_shares":25099921.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-132805000.0,"NetIncomeLoss_2_Q2_USD":-176494000.0,"NetIncomeLoss_1_Q2_USD":-86564000.0,"StockholdersEquity_0_Q2_USD":169704000.0,"Ticker":"ICPT","CIK":"1270073","name":"INTERCEPT PHARMACEUTICALS INC","OfficialName":"Intercept Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"493490879.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]